Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170032/S024

Woven EndoBridge (WEB) Aneurysm Embolization System

Microvention, Inc. · Decision date Oct 27, 2026

MEDTECHLEDGER EXPLANATIONP170032/S024

What did the FDA decide?

The FDA record P170032/S024, dated 2026-10-27, describes a 30-Day Notice for a process change covering manufacturer, sterilizer, packager or supplier. The stated purpose is approval for an alternate supplier of the resin used in the WEB detachment controller housing. The changed item is therefore the resin source for that housing, not the device's clinical use or labeling.

This supplement sits under the original PMA identifier P170032 for a MicroVention intrasaccular flow disruption device in the OPR product code. It is not a new approval of the whole WEB Aneurysm Embolization System. The source does not state resin identity, qualification data, or any conclusion about safety or clinical effectiveness; the reported purpose is regulatory, and independent proof of those outcomes is absent.

FDA approval order statement

approval for an alternate supplier of the resin used in the WEB detachment controller housing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 27, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P170032/S024
Regulatory pathway
PMA supplement
Product code
OPR
Decision code
OK30
Decision date
Oct 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intrasaccular Flow Disruption Device.

Product code
OPR
FDA device class
3

For the original device and its historical approval scope, see PMA P170032. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170032 · Original PMA

    Woven EndoBridge (WEB) Aneurysm Embolization System

  2. P170032/S024 received

    Application receipt date recorded by FDA.

  3. P170032/S024 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P170032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170032

Product / regulatory recordCompanyPathwayDecision dateSource
Microvention, Inc.PMA approvalDec 31, 2018FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Microvention, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
35 Enterprise, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records